SARS-COV-2 (Covid-19) and male fertility: Where are we?
Loading...
Authors
Omolaoye, Temidayo S
Adeniji, Adeloye A
Cardona Maya, Walter D.
Du Plessisa, Stefan S
Issue Date
2020-11-26
Type
Article
Language
en_US
Keywords
SARS-CoV-2 , COVID-19 , Male Fertility
Alternative Title
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS−COV-2), a single-stranded RNA virus, was found to be the causal agent of the disease called coronavirus disease. During December 2019, China informed the World Health Organization (WHO) of an outbreak of cases of pneumonia of unknown etiology, which caused severe-acute respiratory distress. The disease was termed coronavirus disease 2019 (Covid-19). Due to alarming levels of spread and severity, on the 11th of March 2020, the WHO declared the outbreak as a global pandemic. As of September 14, 2020, more than 29 million cases have been reported, with over 900,000 deaths globally. Since the outbreak, although not conclusive, discoveries have been made regarding the understanding of the epidemiology, etiology, clinical features, clinical treatment, and prevention of the disease. SARS−COV-2 has been detected in saliva, respiratory fluids, blood, urine, and faeces. Findings are however controversial regarding its presence in the semen or the testis. Hence, this review aimed to further analyse the literature concerning (i) the effects of previously identified human coronaviruses on male fertility (ii) the impact of Covid-19 on male fertility and (iii) the implication for general health in terms of infection and transmission.
Description
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Citation
Omolaoye, T. S., Adeniji, A. A., Cardona Maya, W. D., & du Plessis, S. S. (2021). SARS-COV-2 (Covid-19) and male fertility: Where are we?. Reproductive toxicology (Elmsford, N.Y.), 99, 65–70. https://doi.org/10.1016/j.reprotox.2020.11.012
Publisher
Reproductive Toxicology